Accelerating drug development and manufacturing

Located in Renfrewshire, Scotland, the Medicines Manufacturing Innovation Centre is a collaboration between CPI, University of Strathclyde, UK Research & Innovation, Scottish Enterprise and founding industry partners, AstraZeneca, and GSK. 

The centre fosters collaboration between industry, academia, healthcare providers and regulators to revolutionise how life-changing medicines are developed. 

By tapping into the centre’s state-of-the-art facilities promoting knowledge exchange and synergy, innovators can overcome technical and regulatory challenges, reduce time to market, gain a competitive edge, and meet the demand for more eco-friendly manufacturing practices. 

Our approach to innovation

Ageing populations, resource constraints, and high drug development costs coupled with the increasing need for cost-effective medication is holding pharma companies back from adopting emergent technologies. 

The aim of the centre is to accelerate the development of a new generation of manufacturing processes – from formulation development to advanced analytical tools – and to help companies integrate these into their existing models. 

Partnering with us

The Medicines Manufacturing Innovation Centre empowers companies of all sizes to enhance their capabilities, drive innovation, and establish themselves as key players in the pharmaceutical industry. 

Together, we can pave the way for ground-breaking therapies and improve patient access to high-quality medicines. Get in touch today to explore opportunities for partnership.